Evidence map›Paper›PMID 31641231›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2020

Metaplastic thymoma: a distinctive thymic neoplasm characterized by YAP1-MAML2 gene fusions.

Marina Vivero, Phani Davineni, Valentina Nardi, John K C Chan, Lynette M Sholl

Open access · bronzeAbstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 69 citations in OpenAlex.

  1. Thymic epithelial tumors: what's next?Cancer metastasis reviews · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. NovelCancers · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The Molecular Landscape of Thymic Epithelial Tumors: A Comprehensive Review.International journal of molecular sciences · 2024
    Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Marina ViveroDepartment of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA. mvivero@partners.org.
Phani DavineniDepartment of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA.
Valentina NardiDepartment of Pathology and Center for Integrative Diagnostics, Massachusetts General Hospital, Boston, MA, USA.
John K C ChanDepartment of Pathology, Queen Elizabeth Hospital, Hong Kong SAR, China.
Lynette M ShollDepartment of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA.
Brigham and Women's Hospital · USMassachusetts General Hospital · USQueen Elizabeth Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metaplastic thymomas are rare biphasic thymic tumors that are characteristically well-circumscribed, confined to the thymus, and follow a benign to indolent clinical course. Their relationship to other thymic neoplasms remains unclear, and their molecular characteristics have not been defined. We report for the first time recurrent translocation events in metaplastic thymomas involving the Yes Associated Protein 1 (YAP1) and Mastermind Like Transcriptional Coactivator 2 (MAML2) genes. Eight metaplastic thymomas were retrieved from two institutions' archives over a 21-year period. Paraffin-embedded material from all cases underwent targeted DNA-based hybrid capture next-generation sequencing. Cases showing no somatic alterations subsequently underwent targeted RNA sequencing. Allele-specific real-time polymerase chain reaction was performed to detect GTF2I c.74146970T>A (p.L424H) mutations. All cases showed characteristic histologic features of metaplastic thymoma and demonstrated no local recurrence or distant metastatic disease at 1-22 years of follow-up. Six of eight cases were successfully sequenced, all showing YAP1-MAML2 fusions; in four cases the fusions were detected by DNA sequencing and in two cases by RNA sequencing. Two distinct products were identified: 5' YAP1 exon 1 fused to 3' MAML2 exons 2-5 or 5' YAP1 exons 1-5 fused to 3' MAML2 exons 2-5. All cases underwent allele-specific real-time polymerase chain reaction and demonstrated no GTF2I L424H mutations. Metaplastic thymoma is a distinct, clinically indolent thymic epithelial neoplasm characterized by YAP1-MAML2 fusion and lacking the GTF2I mutations found in Type A and AB thymomas.

Indexed as

Adaptor Proteins, Signal TransducingAdultBiomarkers, TumorBostonFemaleGene FusionGenetic Predisposition to DiseaseHong KongHumansMaleMetaplasiaMiddle AgedNeoplasms, Glandular and EpithelialThymomaThymus NeoplasmsTrans-ActivatorsAdaptor Proteins, Signal TransducingBiomarkers, TumorMAML2 protein, humanTrans-ActivatorsTranscription FactorsYAP1 protein, humanYAP-Signaling Proteins

Identifiers

PMID31641231
OpenAlexW2981398570

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.